Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Ophthalmology. 2010 Aug;117(8):1506-11. doi: 10.1016/j.ophtha.2009.12.013. Epub 2010 Apr 3.
Evaluation of central and midperipheral vaulting of the posterior chamber phakic intraocular Collamer lens (ICL; Staar Surgical Inc., Monrovia, CA) in eyes with moderate to high myopia.
Retrospective analysis of prospectively collected data.
Eighty-four eyes treated with the latest ICL (V4 model) and 27 eyes treated with early ICL models were examined.
After standardized ICL implantation, patients underwent complete ophthalmologic examinations before surgery and at 1 week, 1 month, 3 months, 6 months, and at yearly intervals thereafter. Central vaulting was measured using the Jaeger device (Haag-Streit, Bern, Switzerland). From 2006 onward, vaulting was measured additionally by optical coherence tomography (Visante OCT; Carl Zeiss Meditec, Jena, Germany). Using the Visante OCT, the crystalline lens rise and the midperipheral vaulting of the ICL were assessed.
Central vaulting after ICL implantation.
The mean duration of follow-up was 74.1+/-23.1 months and 96.3+/-50.2 months in eyes treated with V4 and early models, respectively. Postoperative central vaulting was 466+/-218 microm (range, 30-900 microm) in eyes treated with the V4 models and 321+/-200 microm (range, 150-900 microm) in those treated with early ICL models. From the 6-month follow-up onward, a continuous and nearly linear reduction of central vaulting was observed. At the 10-year follow-up, the mean central vaulting was reduced to 184+/-159 microm (range, 6-500 microm) and 138+/-218 microm (range, 0-820 microm) in eyes treated with V4 or early models, respectively. Eyes with total vaulting had a mean central vaulting of 407+/-202 microm (range, 180-730 microm), whereas those with midperipheral contact had a significantly lower central vaulting of 105+/-87 microm (range, 0-200 microm).
This study revealed consistent reduction of central vaulting over a 10-year period and provides further evidence that insufficient vaulting of the ICL is responsible for the development of anterior subcapsular cataract. A minimum central vaulting of 230 microm seems to be necessary to ensure total vaulting of the ICL. If an ICL is chosen for the correction of myopia, targeting for the greatest possible postoperative central vaulting is advised to achieve safe and complete vaulting for several years.
评估中周部后房型有晶状体眼人工晶状体(ICL;Staar Surgical Inc.,美国加利福尼亚州莫罗维亚)在中高度近视眼中的拱顶高度。
前瞻性收集数据的回顾性分析。
84 只眼接受了最新 ICL(V4 模型)治疗,27 只眼接受了早期 ICL 模型治疗。
标准化 ICL 植入后,患者在术前和术后 1 周、1 个月、3 个月、6 个月以及此后每年进行全面眼科检查。使用 Jaeger 设备(Haag-Streit,瑞士伯尔尼)测量中央拱顶高度。自 2006 年以来,还使用光学相干断层扫描(Visante OCT;Carl Zeiss Meditec,德国耶拿)测量拱顶高度。使用 Visante OCT 评估晶状体升高和 ICL 的中周部拱顶高度。
ICL 植入后的中央拱顶高度。
接受 V4 模型和早期模型治疗的眼的平均随访时间分别为 74.1+/-23.1 个月和 96.3+/-50.2 个月。接受 V4 模型治疗的眼的术后中央拱顶高度为 466+/-218μm(范围,30-900μm),接受早期 ICL 模型治疗的眼为 321+/-200μm(范围,150-900μm)。从 6 个月随访开始,中央拱顶高度呈连续且近乎线性下降。在 10 年随访时,接受 V4 或早期模型治疗的眼的平均中央拱顶高度分别降低至 184+/-159μm(范围,6-500μm)和 138+/-218μm(范围,0-820μm)。总拱顶高度的眼的平均中央拱顶高度为 407+/-202μm(范围,180-730μm),而中周部接触的眼的中央拱顶高度显著较低,为 105+/-87μm(范围,0-200μm)。
本研究揭示了 10 年内中央拱顶高度的持续降低,并进一步证明 ICL 拱顶不足是前囊下白内障发展的原因。ICL 完全拱顶高度至少需要 230μm。如果选择 ICL 治疗近视,建议将目标定在术后中央拱顶高度尽可能大,以在数年内实现安全且完全的拱顶高度。